Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07349810 · ClinicalTrials.gov registry record · Phase 4
Post Operative Infusion Pump Pain Study
A Phase 4 study of Postoperative Pain, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07349810: Recruiting Phase 4 study of Postoperative Pain, sponsored by Rutgers, The State University of New Jersey.
NCT07349810 is a Phase 4 study of Postoperative Pain that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07349810, a Phase 4 study of Postoperative Pain, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotator cuff repair, proximal or distal patellar realignment surgery, open knee arthrotomy cases (i.e. inside out meniscus repair, osteochondral allograft transplantation (OCA), meniscal allograft transplantation (MAT)) at University Center for Ambulatory Surgery, LLC (UOA) will be reviewed for eligibility. Once identified, potential study subjects will be asked whether they are interested in participating in the project. If the patient agrees, the subject will be given the informed consent to read and sign. Objectives: The primary objective is to compare the effectiveness of postoperative infusion pain pump versus preoperative nerve block in reducing visual analog pain scores/numerical pain rating scale (VAS/NPRS) in the postoperative period. The second objective is to evaluate the requirement of narcotic and non-narcotic analgesic medications between the two groups. Hypotheses: Use of continuous infusion pain pump or single shot peripheral block will result in similar post-operative pain control after outpatient sports medicine surgical cases.
Primary Outcome
Compare the effectiveness of postoperative infusion pain pump versus preoperative nerve block in reducing visual analog pain scores/numerical pain rating scale (VAS/NPRS) in the postoperative period. NPRS score difference of approximately 1.5 +/- 1 (approximately 2 points) to detect clinically significant difference in pain score.
Conditions Studied
Interventions
- DRUG Bupivacaine 0.5% Injectable Solution
- DRUG Ropivacaine 0.2% Injectable Solution
- DRUG 1.3% liposomal bupivacaine (Exparel)
- DEVICE ambIT Infusion Pump
Study Locations (1)
New Jersey
- University Center for Ambulatory Surgery - Somerset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
What NCT07349810 shows while recruiting
NCT07349810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which Bupivacaine 0.5% Injectable Solution is the first listed.
NCT07349810 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07349810 about?
NCT07349810 is a clinical study titled "Post Operative Infusion Pump Pain Study". This study will be a pragmatic, prospective cluster randomized trial, where clusters will formed based on sequential 2 week time increments across the study recruitment period.. Patients 18 years or older undergoing ACL reconstruction, open shoulder labrum or rotator cuff surgery, arthroscopic rotat...
What is the current status of trial NCT07349810?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2026-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT07349810 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT07349810?
The interventions under investigation include: Bupivacaine 0.5% Injectable Solution (DRUG), Ropivacaine 0.2% Injectable Solution (DRUG), 1.3% liposomal bupivacaine (Exparel) (DRUG), ambIT Infusion Pump (DEVICE).
Who is sponsoring clinical trial NCT07349810?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07349810 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07349810's enrollment target sits among peer trials
80 69th of 120 higher than 47 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI